5-YEAR SURVIVAL OF NONSMALL-CELL LUNG-CANCER PATIENTS AFTER TREATMENT WITH CHEMOTHERAPY ALONE

被引：0
|
作者：
STATHOPOULOS, GP
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1990年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [31] Is major pathologic response sufficient to predict survival in resectable nonsmall-cell lung cancer patients receiving neoadjuvant chemotherapy?
    Cai, Jing-Sheng
    Li, Shuo
    Yan, Shu-Mei
    Yang, Jie
    Yang, Mu-Zi
    Xie, Chu-Long
    Li, Ji-Bin
    Feng, Yan-Fen
    Yang, Hao-Xian
    Hou, Xue
    THORACIC CANCER, 2021, 12 (09) : 1336 - 1346
  • [32] TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER
    SHEPHERD, FA
    SEMINARS IN ONCOLOGY, 1994, 21 (04) : 7 - 18
  • [33] RADIOTHERAPY ALONE FOR NONSMALL CELL LUNG-CARCINOMA - 5-YEAR DISEASE-FREE SURVIVAL AND PATTERNS OF FAILURE
    KOUKOURAKIS, M
    SKARLATOS, J
    KOSMA, L
    GIATROMANOLAKI, A
    YANNAKAKIS, D
    ACTA ONCOLOGICA, 1995, 34 (04) : 525 - 530
  • [34] LONG-TERM SURVIVAL AFTER CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVES IN PATIENTS WITH ADVANCED UNRESECTABLE NONSMALL CELL LUNG-CANCER
    SCULIER, JP
    PAESMANS, M
    LIBERT, P
    BUREAU, G
    DABOUIS, G
    THIRIAUX, J
    MICHEL, J
    VANCUTSEM, O
    SCHMERBER, J
    GINER, V
    BERCHIER, MC
    SERGYSELS, R
    MOMMEN, P
    KLASTERSKY, J
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1342 - 1347
  • [35] IFOSFAMIDE/CARBOPLATIN/ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH METASTATIC NONSMALL CELL LUNG-CANCER
    CHANG, AY
    ASBURY, RF
    BOROS, L
    GARROW, GC
    HSIEH, S
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 9 - 12
  • [36] Best supportive care versus palliative chemotherapy in nonsmall-cell lung cancer
    Medley, L
    Cullen, M
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (04) : 384 - 388
  • [37] Prevalence of in vitro extreme chemotherapy resistance in resected nonsmall-cell lung cancer
    d'Amato, TA
    Landreneau, RJ
    McKenna, RJ
    Santos, RS
    Parker, RJ
    ANNALS OF THORACIC SURGERY, 2006, 81 (02): : 440 - 447
  • [38] Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer
    Lim, C.
    Tsao, M. S.
    Le, L. W.
    Shepherd, F. A.
    Feld, R.
    Burkes, R. L.
    Liu, G.
    Kamel-Reid, S.
    Hwang, D.
    Tanguay, J.
    Santos, G. da Cunha
    Leighl, N. B.
    ANNALS OF ONCOLOGY, 2015, 26 (07) : 1415 - 1421
  • [39] SURVIVAL AND CHROMOSOME-ABNORMALITIES IN PATIENTS WITH PRIMARY NONSMALL CELL LUNG-CANCER
    IRVING, LB
    LUKEIS, RE
    SMITH, J
    GARSON, OM
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A330 - A330
  • [40] Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients
    Wang, Yanru
    Liu, Hongliang
    Ready, Neal E.
    Su, Li
    Wei, Yongyue
    Christiani, David C.
    Wei, Qingyi
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (11) : 2592 - 2601
12345